Google-backed Tempus AI pops by as much as 15% in Nasdaq debut
Tempus AI, a health-care diagnostics company that uses AI to interpret medical tests to help physicians provide more accurate treatment for their patients, rose by as much as 15% in its Nasdaq Stock Market trading debut on Friday, after going public under the ticker symbol “TEM.” Tempus AI priced 11.1 million shares at $37 apiece … Read more
